• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MAbs . A unified topology-based classification of SARS-CoV-2 RBD neutralizing antibodies systematizes affinity trends across variants

tetano

Editor, Senior Moderator
MAbs


. 2025 Dec;17(1):2575083.
doi: 10.1080/19420862.2025.2575083. Epub 2025 Oct 21. A unified topology-based classification of SARS-CoV-2 RBD neutralizing antibodies systematizes affinity trends across variants

Luis Fernando Cofas-Vargas[SUP] 1 2 [/SUP], Paola Mendoza-Espinosa[SUP] 1 [/SUP], Fernando D Montalvo-Sandoval[SUP] 3 4 [/SUP], Saumel Pérez-Rodríguez[SUP] 5 [/SUP], Jesús Antonio Rauda-Ceja[SUP] 1 4 [/SUP], Pablo Hernández-Peralta[SUP] 6 [/SUP], Adrián Durán-Vargas[SUP] 1 4 [/SUP], Mauricio A Trujillo-Roldán[SUP] 3 [/SUP], Norma A Valdez-Cruz[SUP] 3 [/SUP], Enrique García-Hernández[SUP] 1 [/SUP]



Affiliations
Abstract

The receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein, responsible for engaging the hACE2 receptor, is the principal target of neutralizing antibodies (NAb). To better understand how viral evolution undermines NAb protection, we present a comprehensive, topology-based classification derived from 544 NAbs and 60 nanobody-RBD complex structures. Five major NAb classes, each subdivided into two subclasses, were defined by binding zone, angle of approach, hACE2 competition, and hotspot usage. A systematic mapping of NAb-antigen contacts revealed 91 recurrent hotspot residues, some of which remain fully conserved across all Omicron variants. Leveraging > 2,300 experimentally dissociation constants spanning the Wuhan strain and Omicron lineages, we conducted a comparative affinity analysis across subclasses. NAbs in classes 1-3, which overlap the receptor-binding site, show progressive loss of affinity against Omicron, with many failing to bind recent subvariants due to emergent steric clashes and limited affinity maturation against the ancestral Wuhan RBD. Nonetheless, cases of Abs exhibiting resilience to viral drift have been documented. In contrast, classes 4 and 5 maintain high affinity regardless of their initial affinity for parental strains. Contemporary in-silico epitope predictors captured only ~40% of experimentally defined hotspots, highlighting the need for structure-guided approaches. By introducing a refined topological segmentation of the RBD grounded in previously described but unsystematized regions, our classification captures a broad diversity of NAb binding modes and provides an integrative structural framework that harmonizes prior classification schemes, its relationship with circulating variants, and highlights conserved epitope features relevant to broad-spectrum vaccine and therapeutic NAb design.

Keywords: Affinity evolution; antibody classification; epitope mapping; neutralizing antibodies; receptor binding domain.

 
Back
Top Bottom